MB, Levis & Associates’s iShares Ultra Short Duration Bond Active ETF ICSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$94 Hold
2
– – ﹤0.01% 248
2026
Q2
$93 Hold
2
– – ﹤0.01% 253
2026
Q1
$93 Hold
2
– – ﹤0.01% 232
2025
Q4
$92 Hold
2
– – ﹤0.01% 243
2025
Q3
$91 Hold
2
– – ﹤0.01% 242
2025
Q2
$90 Hold
2
– – ﹤0.01% 264
2025
Q1
$89 Hold
2
– – ﹤0.01% 277
2024
Q4
$88 Hold
2
– – ﹤0.01% 286
2024
Q3
$87 Hold
2
– – ﹤0.01% 287
2024
Q2
$85 Hold
2
– – ﹤0.01% 284
2024
Q1
$84 Hold
2
– – ﹤0.01% 277
2023
Q4
$83 Hold
2
– – ﹤0.01% 272
2023
Q3
$82 Hold
2
– – ﹤0.01% 278
2023
Q2
$80 Sell
2
-450
-100% -$22.6K ﹤0.01% 279
2023
Q1
$22.7K Buy
452
+3
+0.7% +$150 0.02% 153
2022
Q4
$22.5K Buy
+449
New +$22.4K 0.02% 144

Other funds holding ICSH

MB, Levis & Associates's ICSH Position: Q3 2026 in Review

MB, Levis & Associates held its iShares Ultra Short Duration Bond Active ETF (ICSH) position steady in Q3 2026 at 2 shares worth $94. The position accounts for ﹤0.01% of the portfolio, ranked #248.

MB, Levis & Associates first reported a position in ICSH in Q4 2022 and has held it in 16 quarters since. The position peaked at $22.7K in Q1 2023. 162 funds tracked by Wall St. Rank hold ICSH as of Q3 2026.

  • MB, Levis & Associates held 2 shares of iShares Ultra Short Duration Bond Active ETF worth $94 as of Q3 2026.
  • MB, Levis & Associates left its iShares Ultra Short Duration Bond Active ETF share count unchanged in Q3 2026.
  • iShares Ultra Short Duration Bond Active ETF made up ﹤0.01% of MB, Levis & Associates's portfolio in Q3 2026, its #248 holding.
  • MB, Levis & Associates first reported a position in iShares Ultra Short Duration Bond Active ETF in Q4 2022 and has held it in 16 quarters since.
  • MB, Levis & Associates's iShares Ultra Short Duration Bond Active ETF position peaked at $22.7K in Q1 2023.
  • 162 funds tracked by Wall St. Rank held iShares Ultra Short Duration Bond Active ETF as of Q3 2026.

Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.